CG Oncology, Inc.
-
Ticker
CGON
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Irvine, California
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from their innovative immunotherapies to live with dignity and have an enhanced quality of life.
CG Oncology, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K